Journal of Nanobiotechnology · 2022 · 24 citations · 25 references
Life SciencesImmunologyInfectious DiseasesImmunizationVaccine BiotechnologyVaccine ImmunologyAdjuvant DesignAntigen DesignNanomedicineVaccinationVaccine DeliveryVaccine PlatformsNanoformulated VaccinesNanoparticle ImmunogenicityNanoparticle Vaccine FormulationsNanoparticle Vaccine PlatformsNanoparticle-based ImmunotherapyNanovaccinesSelf-assembling NanoparticlesSelf-assembling Vaccine Platforms
BACKGROUND: Nanovaccines have shown the promising potential in controlling and eradicating the threat of infectious diseases worldwide. There has been a great need in developing a versatile strategy to conveniently construct diverse types of nanovaccines and induce potent immune responses. To that end, it is critical for obtaining a potent self-adjuvant platform to assemble with different types of antigens into nanovaccines. RESULTS: In this study, we identified a new natural polysaccharide from the rhizomes of Bletilla striata (PRBS), and used this polysaccharide as a platform to construct diverse types of nanovaccines with potent self-adjuvant property. In the construction process of SARS-CoV-2 nanovaccine, PRBS molecules and RBD protein antigens were assembled into ~ 300 nm nanoparticles by hydrogen bond. For HIV nanovaccine, hydrophobic effect dominantly drove the co-assembly between PRBS molecules and Env expression plasmid into ~ 350 nm nanospheres. Importantly, PRBS can potently activate the behaviors and functions of multiple immune cells such as macrophages, B cells and dendritic cells. Depending on PRBS-mediated immune activation, these self-adjuvant nanovaccines can elicit significantly stronger antigen-specific antibody and cellular responses in vivo, in comparison with their corresponding traditional vaccine forms. Moreover, we also revealed the construction models of PRBS-based nanovaccines by analyzing multiple assembly parameters such as bond energy, bond length and interaction sites. CONCLUSIONS: PRBS, a newly-identified natural polysaccharide which can co-assemble with different types of antigens and activate multiple critical immune cells, has presented a great potential as a versatile platform to develop potent self-adjuvant nanovaccines.
25
Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
Marcus D. Hanwell, Donald Curtis, David Lonie et al. · Journal of Cheminformatics · 2012 · 10.4K citations · Full text
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen, Ajay Nirula, Barry N. Heller et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text
Alexander Zarbock, Mira Küllmar, Detlef Kindgen‐Milles et al. · JAMA · 2020 · 355 citations · Full text
Medicine, Hematology, Nephrology +15
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
Zhaohan Wei, Xiaoqiong Zhang, Tuying Yong et al. · Nature Communications · 2021 · 337 citations · Full text
Life Sciences, Immunology, Oncology +17